Image

Caregiver Burden in Parkinson's Disease

Caregiver Burden in Parkinson's Disease

Recruiting
40-80 years
All
Phase N/A

Powered by AI

Overview

Primary caregivers of patients diagnosed with idiopathic Parkinson's disease will be included in the study. A total of 43 participants will be recruited. At the beginning of the study, demographic data and clinical characteristics of the patients, including disease stage, history of falls, presence of fractures, presence and severity of pain, comorbidities, and medication use, will be recorded.

Subsequently, caregivers' age, gender, occupation, relationship to the patient, caregiving duration, and their own comorbidities will be assessed. Sleep problems will be evaluated using the Insomnia Severity Index (ISI), while symptoms related to depression and anxiety will be assessed with the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be examined using the Zarit Caregiver Burden Scale.

Eligibility

Inclusion Criteria:

  • Age between 40-80 years
  • Diagnosed with Parkinson's disease, Hoehn and Yahr stage 2-5
  • Requires assistance in daily activities
  • Informal caregiver providing care (unpaid, typically a family member such as a spouse or child)
  • Caregiver has sufficient proficiency in Turkish to understand and respond to the study questions

Exclusion Criteria:

  • Presence of any additional neurodegenerative disease other than Parkinson's disease
  • Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
  • Advanced heart failure classified as New York Heart Association (NYHA) Class IV (symptoms at rest)
  • Active cancer disease
  • History of stroke causing limitations in daily life
  • Immobility due to reasons other than Parkinson's disease

Study details
    Parkinson Disease

NCT06892717

Beylikduzu State Hospital

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.